• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Oncology
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
    • Ophthalmology
    • Cell & Gene Therapy
    • Drug Development
    • Small Molecule Research & Development
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • Outsourcing Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Subscribe
Hamburger Menu Hamburger Menu
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Oncology
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
    • Ophthalmology
    • Cell & Gene Therapy
    • Drug Development
    • Small Molecule Research & Development
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • Outsourcing Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Lead Pb on periodic table
Biotech

With $315M raise, AdvanCell puts radiotherapy pedal to the metal

With its new cash in hand, AdvanCell is positioned to stake its own claim in the surging field with a novel isotope, lead-212.
Darren Incorvaia Jul 15, 2026 10:50am
JNJ

J&J axes eye disease gene therapy after key phase 2b readout

Jul 15, 2026 10:26am
Panther Rare Pharmacy

De-Risking a Rare Disease Launch Starts with Precision

Brought to you by PANTHERx® Rare Pharmacy
fundraise tracker 2026

Fierce Biotech Fundraising Tracker '26: AdvanCell, Draig & more

Jul 15, 2026 9:00am
AAIC 2026

AAIC: Roche ‘very interested’ in tau despite amyloid AD focus

Jul 15, 2026 8:42am
IPO initial public offering

Attovia files for IPO to take on Sanofi and Regeneron’s Dupixent

Jul 15, 2026 4:09am
More News
Fierce Pharma

Celcuity set to be Big Pharma 'strategic target' after approval

Jul 14, 2026 4:56pm

FDA plans to release more CRLs as controversial policy resumes

Jul 14, 2026 2:50pm

Biogen defends anti-tau drug after stock slide

Jul 14, 2026 2:00pm

First Bundibugyo Ebola vaccine to enter phase 1 trials

Jul 14, 2026 12:18pm
See more stories
Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Pharma
    • Fierce Biotech
    • Fierce Healthcare
  • Our Events
    • Life Sciences Events
©2026 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings